Harnessing Cerebrospinal Fluid Biomarkers in Clinical Trials for Treating Alzheimer's and Parkinson's Diseases: Potential and Challenges

No disease-modifying therapies (DMT) for neurodegenerative diseases (NDs) have been established, particularly for Alzheimer's disease (AD) and Parkinson's disease (PD). It is unclear why candidate drugs that successfully demonstrate therapeutic effects in animal models fail to show disease...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Neurol
Main Authors: Kim, Dana, Kim, Young-Sam, Shin, Dong Wun, Park, Chang-Shin, Kang, Ju-Hee
Formato: Artigo
Idioma:Inglês
Publicado em: Korean Neurological Association 2016
Assuntos:
Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5063862/
https://ncbi.nlm.nih.gov/pubmed/27819412
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3988/jcn.2016.12.4.381
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados